EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Long‐term risk and predictors of high‐risk human papillomavirus persistence after thermal ablation amongst women living with HIV in West Africa

Simon Boni, Pierre Debaudrap, Firmin N Kabore, Evelyne Kasile-Pooda, Armel Poda, Belarsi Ouattara, Eugene Messou, Brahima Doukoure, Antoine Jaquet iD, Apollinaire Horo, on behalf IeDEA West Africa Collaboration

HIV Medicine · 2025

DOI: 10.1111/hiv.70138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HIV Medicine, 2025. Verfasst von Simon Boni und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Control Program, Abidjan, Côte d'Ivoire. Hauptthemen laut MEDLINE: HIV Infections, Papillomavirus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, Agence Nationale de Recherches sur le Sida et les Hépatites Virales.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mounting evidence supports the use of thermal ablation in women positively screened with high‐risk Human Papillomaviruses ( hrHPV ) but limited data are available on the long‐term post‐treatment outcomes in women living with HIV ( WLHIV ). We aimed to estimate the persistence of hrHPV infection amongst WLHIV ≥24 months post treatment in West Africa.

Methods

From October 2019 to October 2024, a cohort study was conducted amongst WLHIV in two HIV clinics in Burkina Faso and Cote d'Ivoire. All WLHIV with a positive hrHPV test who received thermal ablation were followed up ≥24 months. During follow‐up visits, DNA HPV testing, visual inspection and biopsy were systematically performed. Factors associated with ≥24 months hrHPV positivity were assessed through a logistic regression model.

Results

A total of 200 WLHIV , aged 42 years [Interquartile range ( IQR ): 38–45], with a nadir CD4 of 365 [ IQR : 168–616] cell/mm 3 received thermal ablation and were followed for a median time of 42 [ IQR : 29–48] months. A positive hrHPV was detected in 40.5% of women ≥24 months post treatment. WLHIV who had a nadir CD4 count ≤200 cell/mm 3 ( aOR = 3.06 [95% CI : 1.23–7.59]) or had no or a primary school level ( aOR = 2.25 [95% CI : 1.13–4.49]) were more likely to present at ≥24 months with hrHPV infection.

Conclusion

Post‐therapeutic hrHPV infection remains high beyond 2 years in WLHIV stressing the need for long‐term follow‐up, especially when diagnosed with advanced HIV disease. Future implementation research should focus on the contribution of additional tools to better track those in need of additional treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPapillomavirus InfectionsHumansFemaleAdultMiddle AgedCote d'IvoireBurkina FasoCohort StudiesRisk FactorsPapillomaviridaeHuman Papillomavirus Viruses

Stichwörter der Autor:innen

HIVWest Africahigh‐risk human papillomavirusespersistenceprecancerous lesions

Autor:innen und Institutionen

  • National Cancer Control Program, Abidjan, Côte d'Ivoire.
  • National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, University of Bordeaux, Bordeaux, France.
  • Programme PACCI, Treichville, Abidjan, Côte d'Ivoire.
  • Institut de Recherche pour le Développement (IRD)/Centre Population et Développement (CEPED) UMR 196, Paris, France.
  • Centre Muraz, National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.
  • Department of Gynecology and Obstetrics, University Hospital of Yopougon, Abidjan, Côte d'Ivoire.

ORCID-Profile: Antoine Jaquet

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • Agence Nationale de Recherches sur le Sida et les Hépatites Virales
  • National Institutes of Health

Zitieren

APA

Boni, S., Debaudrap, P., Kabore, F. N., Kasile-Pooda, E., Poda, A., Ouattara, B., Messou, E., Doukoure, B., Jaquet, A., Horo, A., & on behalf IeDEA West Africa Collaboration (2025). Long‐term risk and predictors of high‐risk human papillomavirus persistence after thermal ablation amongst women living with HIV in West Africa. HIV Medicine. https://doi.org/10.1111/hiv.70138

Vancouver

Boni S, Debaudrap P, Kabore FN, Kasile-Pooda E, Poda A, Ouattara B, et al. Long‐term risk and predictors of high‐risk human papillomavirus persistence after thermal ablation amongst women living with HIV in West Africa. HIV Medicine. 2025. doi:10.1111/hiv.70138

BibTeX
@article{Boni2025,
  author = {Boni, Simon and Debaudrap, Pierre and Kabore, Firmin N and Kasile-Pooda, Evelyne and Poda, Armel and Ouattara, Belarsi and Messou, Eugene and Doukoure, Brahima and Jaquet, Antoine and Horo, Apollinaire and on behalf IeDEA West Africa Collaboration, on behalf IeDEA West Africa Collaboration},
  title = {Long‐term risk and predictors of high‐risk human papillomavirus persistence after thermal ablation amongst women living with HIV in West Africa},
  journal = {HIV Medicine},
  year = {2025},
  doi = {10.1111/hiv.70138}
}
Kostenlos starten →